TY  - GEN
AU  - Taylor,Graham S
AU  - Jia,Hui
AU  - Harrington,Kevin
AU  - Lee,Lip Wai
AU  - Turner,James
AU  - Ladell,Kristin
AU  - Price,David A
AU  - Tanday,Manjit
AU  - Matthews,Jen
AU  - Roberts,Claudia
AU  - Edwards,Ceri
AU  - McGuigan,Lesley
AU  - Hartley,Andrew
AU  - Wilson,Steve
AU  - Hui,Edwin P
AU  - Chan,Anthony T C
AU  - Rickinson,Alan B
AU  - Steven,Neil M
TI  - A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer
SN  - 1557-3265
PY  - 2015///0625
KW  - Adult
KW  - Aged
KW  - Cancer Vaccines
KW  - administration & dosage
KW  - Combined Modality Therapy
KW  - Epitopes, T-Lymphocyte
KW  - immunology
KW  - Epstein-Barr Virus Infections
KW  - complications
KW  - Epstein-Barr Virus Nuclear Antigens
KW  - genetics
KW  - Female
KW  - Herpesvirus 4, Human
KW  - Humans
KW  - Immunophenotyping
KW  - Lymphocyte Count
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Neoplasms
KW  - diagnosis
KW  - T-Cell Antigen Receptor Specificity
KW  - T-Lymphocyte Subsets
KW  - Treatment Outcome
KW  - Vaccination
KW  - Vaccinia virus
KW  - Viral Load
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1158/1078-0432.CCR-14-1122-T
ER  -